Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 14 studies | 24% ± 8% | |
| brain | 9 studies | 34% ± 17% | |
| lung | 8 studies | 25% ± 8% | |
| eye | 4 studies | 27% ± 8% | |
| intestine | 4 studies | 23% ± 8% | |
| adipose | 4 studies | 19% ± 1% | |
| bone marrow | 3 studies | 18% ± 1% | |
| lymph node | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 5555.76 | 21 / 21 | 100% | 34.55 | 504 / 504 |
| esophagus | 100% | 5801.24 | 1445 / 1445 | 100% | 33.90 | 183 / 183 |
| intestine | 100% | 6873.34 | 966 / 966 | 100% | 31.78 | 527 / 527 |
| lung | 100% | 6034.74 | 578 / 578 | 100% | 35.29 | 1155 / 1155 |
| ovary | 100% | 7245.70 | 180 / 180 | 100% | 35.42 | 430 / 430 |
| prostate | 100% | 6508.62 | 245 / 245 | 100% | 35.93 | 502 / 502 |
| stomach | 100% | 4862.97 | 359 / 359 | 100% | 30.81 | 286 / 286 |
| uterus | 100% | 8277.21 | 170 / 170 | 100% | 39.45 | 459 / 459 |
| breast | 100% | 5729.27 | 459 / 459 | 100% | 39.18 | 1117 / 1118 |
| thymus | 100% | 7540.74 | 653 / 653 | 100% | 37.94 | 604 / 605 |
| pancreas | 100% | 3168.16 | 327 / 328 | 100% | 31.89 | 178 / 178 |
| brain | 100% | 4476.58 | 2631 / 2642 | 100% | 37.96 | 705 / 705 |
| liver | 100% | 3023.58 | 226 / 226 | 99% | 19.98 | 403 / 406 |
| kidney | 100% | 4475.89 | 89 / 89 | 99% | 27.20 | 892 / 901 |
| adrenal gland | 100% | 4344.99 | 258 / 258 | 98% | 27.40 | 226 / 230 |
| skin | 100% | 5656.24 | 1809 / 1809 | 97% | 26.10 | 457 / 472 |
| adipose | 100% | 5393.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.35 | 29 / 29 |
| muscle | 100% | 4685.96 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7821.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 32.64 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 17.18 | 1 / 1 |
| blood vessel | 100% | 4924.10 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 3305.08 | 852 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 3731.28 | 881 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 18.82 | 73 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0017145 | Biological process | stem cell division |
| GO_2000648 | Biological process | positive regulation of stem cell proliferation |
| GO_0072089 | Biological process | stem cell proliferation |
| GO_0035332 | Biological process | positive regulation of hippo signaling |
| GO_0007281 | Biological process | germ cell development |
| GO_0006915 | Biological process | apoptotic process |
| GO_2000637 | Biological process | positive regulation of miRNA-mediated gene silencing |
| GO_0006952 | Biological process | defense response |
| GO_0044194 | Cellular component | cytolytic granule |
| GO_0005764 | Cellular component | lysosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0010494 | Cellular component | cytoplasmic stress granule |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0140517 | Molecular function | protein-RNA adaptor activity |
| GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0003730 | Molecular function | mRNA 3'-UTR binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TIAL1 |
| Protein name | TIA1 cytotoxic granule associated RNA binding protein like 1 T-cluster binding protein (TIA1 cytotoxic granule-associated RNA binding protein-like 1, isoform CRA_a) TIAL1 protein Nucleolysin TIAR (TIA-1-related protein) |
| Synonyms | hCG_40603 |
| Description | FUNCTION: RNA-binding protein involved in alternative pre-RNA splicing and in cytoplasmic stress granules formation . Shows a preference for uridine-rich RNAs . Activates splicing of alternative exons with weak 5' splice sites followed by a U-rich stretch on its own pre-mRNA and on TIA1 mRNA (By similarity). Promotes the inclusion of TIA1 exon 5 to give rise to the long isoform (isoform a) of TIA1 . Acts downstream of the stress-induced phosphorylation of EIF2S1/EIF2A to promote the recruitment of untranslated mRNAs to cytoplasmic stress granules (SG) . Possesses nucleolytic activity against cytotoxic lymphocyte target cells . May be involved in apoptosis . . |
| Accessions | E7ETJ9 A0A087WX93 Q01085 ENST00000369086.1 ENST00000436547.7 [Q01085-1] O15187 ENST00000369093.6 [Q01085-2] ENST00000497671.5 E7ETC0 Q49AS9 A6NKZ9 ENST00000412524.5 ENST00000479729.1 |